About the company

Karl is an enthusiastic entrepreneur and passionate about medical devices. He has many years of experience in the medical device industry with an emphasis on early stage start-up companies. He is co-founder of Protembis and has served as Co-CEO since 2013. Karl graduated from the University of Mannheim and ESCP Business School where he received his M.Sc. degree.

Conrad builds companies. He has many years of experience in the start-up world and a strong background in funding companies. Before co-founding Protembis he was an M&A and debt advisor. Conrad has served as Co-CEO of Protembis since 2013. Conrad graduated from the University of Mannheim and ESCP Business School where he received his Dipl. Kfm. and M.Sc. degrees.

Oliver is a medtech industry veteran. He has over 20 years of experience in the medical device industry. Prior to joining Protembis he co-founded CircuLite and developed the world’s first micro-pump for partial support of chronic heart failure patients. Oliver has served as CTO at Protembis since 2015. He graduated from RWTH Aachen University where he received his Dipl.-Ing. degree.

Stefanie, with nearly 25 years of experience in the medical device and pharma industry (e.g. Johnson&Johnson, Bayer), specializes in efficient quality and risk management systems. She has secured EU and international market approvals for various medical and drug-device products. Since 2015, she has served as Protembis QMB and Head of QM/RA. Stefanie holds a Dipl. Biochem. from the University of Halle and a Dr. rer. nat. from the University of Aachen.

Nawzer has over 35 years of experience in clinical research and Class III device approvals in the US, EU, and China. He has held leadership roles at Lungpacer, Olympus, Claret Medical, Cardiac Dimensions, Medtronic, and Biotronik. Nawzer holds a PhD in Cardiovascular Physiology from St. George’s, London, and a BSc in Human Biology from the University of Surrey.

James has 35 years of experience in corporate roles at Medtronic, Guidant, Cordis, and St. Jude Medical, as well as several start-ups. Notably, he was Chief Commercial Officer at Claret Medical (acquired by Boston Scientific). With expertise in sales, strategic marketing, and a strong network in interventional cardiology, he has successfully introduced novel technologies to global markets.

Melanie has international expertise in securing regulatory approvals for clinical studies and market entry, backed by her strong background as an R&D engineer in the medical device industry. She holds a diploma in biochemical engineering and earned her Ph.D. from Utrecht University, Netherlands. Melanie plays an important role in shaping Protembis’ regulatory strategies and ensuring compliance to improve patient care worldwide.